Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Electrophysiology Lab Systems are used for the visualization, diagnosis and treatment of cardiac arrhythmias. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrophysiology lab systems devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the electrophysiology lab systems market in the US was Abbott Laboratories followed by Biosense Webster, GE HealthCare Technologies, Fischer Medical Technologies, Koninklijke Philips, Micropace EP, Medtronic, Boston Scientific, Siemens Healthineers and Acutus Medical.
Different components are tracked in Electrophysiology Lab Systems, including Electrophysiology 3D Mapping Systems, Electrophysiology Recording Systems, Intracardiac Echocardiography (ICE) Systems, Electrophysiology Radio Frequency Ablation (RFA) Generators, and Cardiac Stimulators. An electrophysiology 3D Mapping System allows electrophysiologists to navigate the heart and place catheters during an electrophysiology study. An Electrophysiology Recording System allows electrophysiologists to record information on the electrical activity of the patient’s heart during an electrophysiology study, including signals from surface and intracardiac electrograms, cardiac stimulators and other monitoring systems such as hemodynamic monitoring system. The Intracardiac Echocardiography (ICE) System is an ultrasound console that use echocardiography to provide real-time image and guidance of cardiac structures during electrophysiology interventions’. Electrophysiology Radiofrequency Ablation (RFA) Generators utilize radiofrequency energy for ablation interventions. A Cardiac Stimulator is a device that induces temporary cardiac pacing during an electrophysiology study.
The value of the electrophysiology lab systems devices market within the US was expected to be over $400m in 2023.
For the latest complete market share analysis of electrophysiology lab systems device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
